Set-point shifts in peri-anesthetic fluid homeostasis: a conceptual framework informed by α2-agonist diuresis

Peri-anesthetic fluid handling is marked by an apparent contrast: general anesthesia often suppresses urinary excretion of administered fluid, whereas α 2-agonists such as dexmedetomidine can produce sustained, often dilute polyuria with a risk of hypernatremia. This article proposes a working set-point-shift model in which these opposing phenotypes are interpreted as state-dependent changes in the operating point of fluid regulation. Here, set-point is used operationally to describe a testable shift in the relation between filling state and urine-output phenotype, not to imply that a new defended reference value has already been experimentally demonstrated. Within this framework, general anesthesia is viewed as establishing a wet-biased, retention-biased state through convergent hemodynamic, neuroendocrine, and autonomic influences, whereas α 2-agonists may oppose this bias and shift the system toward a dry-biased, excretion-permissive state through AVP-linked, sympatholytic, and potentially peripheral α 2-dependent pathways. Human peri-anesthetic reports and comparative veterinary physiology provide convergent support for altered regulatory behavior, although the evidence remains insufficient to prove a single governing mechanism. The model generates measurable predictions: greater α 2-agonist exposure should increase the probability, earlier emergence, and persistence of dilute polyuria; α 2-associated polyuria should show serial urine and serum osmotic trajectories consistent with free-water loss when replacement is inadequate; and, during general anesthesia without α 2 exposure, breakthrough diuresis should emerge nonlinearly only after cumulative filling and related venous, atrial, or neuroendocrine permissive signals cross a threshold under relatively stable global hemodynamics. Thus, anesthetic oliguria and α 2-associated polyuria are framed as opposing phenotypes that generate testable predictions about peri-anesthetic fluid regulation, rather than as unrelated bedside anomalies.